You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-LYVE1 (LYVE1) Antibodies

Full name:
anti-Lymphatic Vessel Endothelial Hyaluronan Receptor 1 Antibodies (LYVE1)
On www.antibodies-online.com are 261 Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1) Antibodies from 27 different suppliers available. Additionally we are shipping LYVE1 Proteins (34) and LYVE1 Kits (18) and many more products for this protein. A total of 323 LYVE1 products are currently listed.
Synonyms:
1200012G08Rik, Crsbp-1, HAR, Lyve-1, LYVE1, Xlkd1
list all antibodies Gene Name GeneID UniProt
LYVE1 10894 Q9Y5Y7
LYVE1 114332 Q8BHC0
LYVE1 293186  

Show all species

Show all synonyms

All available anti-LYVE1 Antibodies

Go to our pre-filtered search.

Top referenced anti-LYVE1 Antibodies

  1. Mouse (Murine) Polyclonal LYVE1 Primary Antibody for EIA, FACS - ABIN115689 : Jackson: The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1. in Trends in cardiovascular medicine 2003 (PubMed)
    Show all 7 references for ABIN115689

  2. Human Polyclonal LYVE1 Primary Antibody for EIA, IHC (p) - ABIN357391 : Cursiefen, Schlötzer-Schrehardt, Küchle, Sorokin, Breiteneder-Geleff, Alitalo, Jackson: Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin. in Investigative ophthalmology & visual science 2002 (PubMed)
    Show all 5 references for ABIN357391

  3. Mouse (Murine) Monoclonal LYVE1 Primary Antibody for FACS, IHC (p) - ABIN1449242 : Hirashima, Sano, Morisada, Murakami, Rossant, Suda: Lymphatic vessel assembly is impaired in Aspp1-deficient mouse embryos. in Developmental biology 2008 (PubMed)
    Show all 4 references for ABIN1449242

  4. Human Polyclonal LYVE1 Primary Antibody for EIA, FACS - ABIN115663 : Mouta Carreira, Nasser, di Tomaso, Padera, Boucher, Tomarev, Jain: LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. in Cancer research 2001 (PubMed)
    Show all 4 references for ABIN115663

  5. Mouse (Murine) Polyclonal LYVE1 Primary Antibody for EIA, FACS - ABIN126137 : Sleeman, Krishnan, Kirkin, Baumann: Markers for the lymphatic endothelium: in search of the holy grail? in Microscopy research and technique 2001 (PubMed)
    Show all 3 references for ABIN126137

  6. Human Polyclonal LYVE1 Primary Antibody for EIA, IHC (p) - ABIN357392 : Cunnick, Jiang, Gomez, Mansel: Lymphangiogenesis quantification using quantitative PCR and breast cancer as a model. in Biochemical and biophysical research communications 2001 (PubMed)
    Show all 3 references for ABIN357392

  7. Human Polyclonal LYVE1 Primary Antibody for IHC (p), WB - ABIN388751 : Banerji, Ni, Wang, Clasper, Su, Tammi, Jones, Jackson: LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. in The Journal of cell biology 1999 (PubMed)
    Show all 2 references for ABIN388751

  8. Human Polyclonal LYVE1 Primary Antibody for WB - ABIN616055 : Heindl, Hofmann, Adler, Knorr, Holbach, Naumann, Kruse, Cursiefen: Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension? in Ophthalmology 2010 (PubMed)
    Show all 2 references for ABIN616055

  9. Cow (Bovine) Polyclonal LYVE1 Primary Antibody for WB - ABIN2782730 : Ishikawa, Akishima-Fukasawa, Ito, Akasaka, Yokoo, Ishii: Histopathologic determinants of regional lymph node metastasis in early colorectal cancer. in Cancer 2008 (PubMed)

More Antibodies against LYVE1 Interaction Partners

Human Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1) interaction partners

  1. These findings reveal binding is dependent not just on clustering but also on the biochemical properties of LYVE-1 homodimers. They also mark LYVE-1 as the first Link protein (show HAPLN1 Antibodies) superfamily member requiring covalent homodimerization for function and suggest the interchain disulfide acts as a redox switch in vivo.

  2. LYVE1 expression is significantly upregulated in human masticatory mucosa during wound healing

  3. Immunostaining analyses in psoria (show VEGFA Antibodies)sis skin lesions suggested that the ectodomain shedding of LYVE-1 occurred in lymphatic vessels undergoing chronic inflammation. These results indicate that the ectodomain shedding of LYVE-1 might be involved in promoting pathological lymphangiogenesis.

  4. These results demonstrate the prerequisite of a critical LYVE-1 threshold density and show that hyaluronan binding may be elicited in lymphatic endothelium by surface clustering with divalent LYVE-1 mAbs.

  5. We have established a novel, three-protein biomarker panel that is able to detect patients with early-stage pancreatic cancer in urine specimens:LYVE-1, REG1A (show REG1A Antibodies), and TFF1 (show TFF1 Antibodies) were selected as candidate biomarkers

  6. Data (including data from studies in knockout mice) suggest LYVE1 mediates adhesion of group A Streptococci (GAS) to lymphatic vesicular endothelium via capsular hyaluronan; this appears to be critical factor for lymphatic trafficking of GAS in vivo.

  7. High expression of LYVE-1 is associated with atherosclerotic arteries.

  8. Data indicate that detection of lymphatic vascular invasion (LVI) can be optimized by specific D2-40 or LYVE-1 staining.

  9. High-low cell surface HA content of tumor cells through the interaction with LYVE-1 leads to adhesion differences.

  10. FGF2 (show FGF2 Antibodies) binds to LYVE-1 with a higher affinity than any other known LYVE-1-binding molecules, such as hyaluronan or PDGF (show PDGFA Antibodies)-BB. Glycosylation of LYVE-1 is important for FGF2 (show FGF2 Antibodies) binding.

Mouse (Murine) Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1) interaction partners

  1. the LYVE-1-expressing cells might be involved in the uptake of hyaluronan and other waste products as well as foreign particles circulating in the blood and lymph while participating in the subsequent degradation in relay with adjacent macrophage populations.

  2. Immunostaining analyses in VEGF-A (show VEGFA Antibodies) transgenic skin suggested that the ectodomain shedding of LYVE-1 occurred in lymphatic vessels undergoing chronic inflammation. These results indicate that the ectodomain shedding of LYVE-1 might be involved in promoting pathological lymphangiogenesis.

  3. Endogenous hyaluronan on the surface of macrophages can engage LYVE-1, facilitating their adhesion and transit across lymphatic endothelium.

  4. MT1-MMP (show MMP14 Antibodies) directly cleaves LYVE-1 on lymphatic endothelial cells to inhibit LYVE-1-mediated lymphangiogenic responses and restrains the production of VEGF-C (show VEGFC Antibodies).

  5. Data (including data from studies in knockout mice) suggest Lyve1 mediates adhesion of group A Streptococci (GAS) to lymphatic vesicular endothelium via capsular hyaluronan; this appears to be critical factor for lymphatic trafficking of GAS in vivo.

  6. Data show that the expression of lymphatic vessel endothelial hyaluronan receptor 1 (LYVE 1) was similar with vascular endothelial growth factor C (VEGF-C (show VEGFC Antibodies)), but its peak appeared 1-2 d later than that of VEGF-C (show VEGFC Antibodies).

  7. LMW-HA may play a critical role in the processes required for lymphangiogenesis through interactions with its receptor LYVE-1 and triggering intracellular signal cascades.

  8. Studied the specific targeting property of lymphatic vessel endothelial hyaluronan receptor-1 binding polyethylene glycol-coated ultrasmall superparamagnetic iron oxide (LYVE-1-PEG (show PAEP Antibodies)-USPIO) nanoparticles to mouse lymphatic endothelial cells.

  9. Reelin (show RELN Antibodies)-deficient mice showed abnormal collecting lymphatic vessels, characterized by a reduced number of SMCs, abnormal expression of lymphatic capillary marker lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1), and impaired function

  10. report intact CD31 (show PECAM1 Antibodies)(+) corneal lymphatic capillary endothelial cells that do not express LYVE-1. The number of LYVE-1(-) gaps initially increased until 8 wk of age but was significantly reduced in aged mice.

Cow (Bovine) Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1) interaction partners

  1. CRSBP-1 plays a role in autocrine regulation of cell growth mediated by growth regulators containing cell surface retention sequence.

LYVE1 Antigen Profile

Antigen Summary

This gene encodes a type I integral membrane glycoprotein. The encoded protein acts as a receptor and binds to both soluble and immobilized hyaluronan. This protein may function in lymphatic hyaluronan transport and have a role in tumor metastasis.

Alternative names and synonyms associated with LYVE1

  • lymphatic vessel endothelial hyaluronic acid receptor 1-like (LOC560618) antibody
  • lymphatic vessel endothelial hyaluronan receptor 1 (LOC100347960) antibody
  • lymphatic vessel endothelial hyaluronan receptor 1 (LYVE1) antibody
  • lymphatic vessel endothelial hyaluronan receptor 1 (Lyve1) antibody
  • 1200012G08Rik antibody
  • Crsbp-1 antibody
  • HAR antibody
  • Lyve-1 antibody
  • LYVE1 antibody
  • Xlkd1 antibody

Protein level used designations for LYVE1

lymphatic vessel endothelial hyaluronan receptor 1 , extracellular link domain containing 1 , lymphatic endothelial hyaluronan receptor LYVE-1 , lymphatic vessel endothelial hyaluronic acid receptor 1 , cell surface retention sequence binding protein-1 , cell surface retention sequence-binding protein 1 , extracellular link domain-containing 1 , extracellular link domain-containing protein 1 , hyaluronic acid receptor , extra cellular link domain-containing 1 , lymphatic vessel endothelial HA receptor-1 , lymphatic vessel endothelial HA recptor-1

GENE ID SPECIES
560618 Danio rerio
100347960 Oryctolagus cuniculus
397626 Sus scrofa
423038 Gallus gallus
451024 Pan troglodytes
611529 Canis lupus familiaris
702941 Macaca mulatta
10894 Homo sapiens
114332 Mus musculus
293186 Rattus norvegicus
404179 Bos taurus
Selected quality suppliers for anti-LYVE1 (LYVE1) Antibodies
Did you look for something else?